• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物组与健康和疾病:新兴的诊断机会。

Gut Microbiome in Health and Disease: Emerging Diagnostic Opportunities.

机构信息

Department of Medicine, APC Microbiome Ireland, University College Cork, Cork, Ireland.

School of Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.

出版信息

Gastroenterol Clin North Am. 2019 Jun;48(2):221-235. doi: 10.1016/j.gtc.2019.02.003. Epub 2019 Apr 5.

DOI:10.1016/j.gtc.2019.02.003
PMID:31046972
Abstract

The gut microbiome is fundamental to human health and development. Altered microbiomes have been associated with many diseases. However, variation between individuals, environmental effects, and a lack of standardization across studies makes differentiation between health and disease challenging. Large-scale population cohorts in different countries will be required to match disease subjects with healthy controls, whereas standardized, reproducible pipelines for analysis are required to compare findings between studies. Despite this, several conditions have already demonstrated great promise for developing microbiome-based biomarkers as well as providing a gateway into integrated personalized medicine.

摘要

肠道微生物组对人类健康和发育至关重要。微生物组的改变与许多疾病有关。然而,个体之间的差异、环境影响以及研究之间缺乏标准化,使得区分健康和疾病具有挑战性。需要在不同国家的大型人群队列中匹配疾病受试者与健康对照,同时需要标准化、可重复的分析管道来比较研究结果。尽管如此,一些疾病已经显示出很大的潜力,可以开发基于微生物组的生物标志物,并为整合个性化医学提供途径。

相似文献

1
Gut Microbiome in Health and Disease: Emerging Diagnostic Opportunities.肠道微生物组与健康和疾病:新兴的诊断机会。
Gastroenterol Clin North Am. 2019 Jun;48(2):221-235. doi: 10.1016/j.gtc.2019.02.003. Epub 2019 Apr 5.
2
[Microbiota and inflammatory bowel disease: an update.].[微生物群与炎症性肠病:最新进展。]
Recenti Prog Med. 2018 Dec;109(12):570-573. doi: 10.1701/3082.30741.
3
Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists.炎症性肠病中的粪便微生物移植:内科医生入门。
Am J Med. 2018 Sep;131(9):1017-1024. doi: 10.1016/j.amjmed.2018.03.010. Epub 2018 Mar 29.
4
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.肠道微生物群、粪便微生物群移植与炎症性肠病
Gut Microbes. 2017 May 4;8(3):238-252. doi: 10.1080/19490976.2017.1290757. Epub 2017 Feb 10.
5
The microbiota in inflammatory bowel disease.炎症性肠病中的微生物组。
J Gastroenterol. 2015 May;50(5):495-507. doi: 10.1007/s00535-015-1064-1. Epub 2015 Mar 26.
6
The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.炎症性肠病粪便微生物群移植的现状与启示:过去、现在和未来。
Inflamm Bowel Dis. 2017 Oct;23(10):1710-1717. doi: 10.1097/MIB.0000000000001247.
7
Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.调节炎症性肠病患者肠道微生物群的组成和代谢活性
Int J Mol Sci. 2016 Apr 19;17(4):578. doi: 10.3390/ijms17040578.
8
Fecal microbiota transplantation for gastrointestinal disorders.用于胃肠道疾病的粪便微生物群移植
Curr Opin Gastroenterol. 2017 Jan;33(1):8-13. doi: 10.1097/MOG.0000000000000326.
9
Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.炎症性肠病中肠道微生物群的治疗性调节:更多问题有待解答。
J Dig Dis. 2016 Dec;17(12):800-810. doi: 10.1111/1751-2980.12422.
10
Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician.我们对肠道微生物群认识的进展:对临床医生的启示
Curr Gastroenterol Rep. 2016 Sep;18(9):49. doi: 10.1007/s11894-016-0524-y.

引用本文的文献

1
CODARFE: Unlocking the prediction of continuous environmental variables based on microbiome.CODARFE:基于微生物组实现对连续环境变量的预测
Gigascience. 2025 Jan 6;14. doi: 10.1093/gigascience/giaf055.
2
Causal Relationship Between Gut Microbiota and Gastrointestinal Polyps: A Mendelian Randomization Study.肠道微生物群与胃肠道息肉之间的因果关系:一项孟德尔随机化研究
Turk J Gastroenterol. 2025 Jan 6;36(5):302-311. doi: 10.5152/tjg.2025.24347.
3
Therapeutic role of gut microbiota in lung injury-related cognitive impairment.肠道微生物群在肺损伤相关认知障碍中的治疗作用。
Front Nutr. 2025 Feb 13;11:1521214. doi: 10.3389/fnut.2024.1521214. eCollection 2024.
4
Potential probiotic and functional properties of strains isolated from kombucha tea.从康普茶中分离出的菌株的潜在益生菌特性和功能特性。
Front Microbiol. 2024 Jul 23;15:1415616. doi: 10.3389/fmicb.2024.1415616. eCollection 2024.
5
Understanding from Probiotic Properties to Omics Technology: A Review.从益生菌特性到组学技术的理解:综述
Foods. 2024 Mar 15;13(6):895. doi: 10.3390/foods13060895.
6
Microbial dysbiosis index for assessing colitis status in mouse models: A systematic review and meta-analysis.用于评估小鼠模型结肠炎状态的微生物失调指数:系统评价与荟萃分析
iScience. 2023 Dec 6;27(1):108657. doi: 10.1016/j.isci.2023.108657. eCollection 2024 Jan 19.
7
High association of COVID-19 severity with poor gut health score in Lebanese patients.黎巴嫩患者的 COVID-19 严重程度与肠道健康评分差密切相关。
PLoS One. 2021 Oct 21;16(10):e0258913. doi: 10.1371/journal.pone.0258913. eCollection 2021.
8
Gut-Lung Axis in COVID-19.新冠病毒肺炎中的肠-肺轴
Interdiscip Perspect Infect Dis. 2021 Mar 12;2021:6655380. doi: 10.1155/2021/6655380. eCollection 2021.
9
Enduring neurobehavioral effects induced by microbiota depletion during the adolescent period.青少年时期肠道菌群耗竭导致的持久神经行为效应。
Transl Psychiatry. 2020 Nov 6;10(1):382. doi: 10.1038/s41398-020-01073-0.
10
Immunostimulation by S-layer proteins with distinct glycosylation patterns requires different lectin partners.具有不同糖基化模式的 S-层蛋白通过免疫刺激需要不同的凝集素伴侣。
J Biol Chem. 2020 Oct 16;295(42):14430-14444. doi: 10.1074/jbc.RA120.013934. Epub 2020 Aug 13.